The company has not filed an annual or quarterly report since its FY2018 10-K, filed May 30, 2018. Its latest SEC filing is a SC 13G/A from Sep 27, 2018.
10-K for FY2018, filed May 30, 2018
The sections below describe the company as of the FY2018 annual report.
Sold portable blood-analysis instruments and consumables for veterinary and human patient care, serving veterinary practices and human healthcare providers.
10-K for FY2018, filed May 30, 2018Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of…View ↗
point-of-care diagnostic instruments and consumables used in the medical market; and point-of-care diagnostic instruments and consumables…View ↗
In the veterinary market, our VetScan products serve a worldwide customer group consisting of companion animal hospitals, animal clinics…View ↗
Sold worldwide through direct sales forces and independent distributors. Medical products went mainly through distributors, with Abbott serving as exclusive distributor for specified U.S. human-healthcare sales; veterinary products went through distributors and directly to large buying groups and hospital networks.
10-K for FY2018, filed May 30, 2018Sales and MarketingView ↗
For our products in the human medical market, we employ primarily independent distributors to market our products. Starting in January…View ↗
For our products in the veterinary market, we employ a combination of direct sales and independent distributors. Veterinarians are served…View ↗
In addition to selling through distributors, we also directly supply our VetScan products to large group purchasing organizations, hospital…View ↗
10-K for FY2018, filed May 30, 2018
8-K, filed Jul 31, 2018
On July 31, 2018 (the “Closing Date”), Abaxis, Inc., a California corporation (the “Company”) completed its previously announced merger…View ↗
Competes with Alere, Alfa Wassermann, Ortho Clinical Diagnostics, F. Hoffmann-La Roche, Abbott, Idexx Laboratories, and Heska
10-K for FY2018, filed May 30, 2018Our principal competitors in the point-of-care human medical diagnostic market are Alere Inc., Alfa Wassermann S.P.A., Ortho Clinical…View ↗
Loading...
